REG - Morgan Stanley&CoLLC - Rule 38.5 - ABBVIE INC.

Morgan StanleyAnnouncement

16/04/2020 11:25

RNS Number : 8822J
  
Morgan Stanley & Co. LLC
  
16 April 2020
  
 

 
 FORM 38.5 
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2007 (AS AMENDED)
 
DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS
 
1.             KEY INFORMATION



 Name of exempt market-maker


   Morgan Stanley & Co. LLC




 Company dealt in


   ABBVIE INC.




 Class of relevant security to which the dealings being disclosed relate (Note 1)


  US$0.01 COMMON STOCK




 Date of dealing


   15 APRIL 2020



 
 
2.             DEALINGS (Note 2)
 
(a)           Purchases and sales



 Total number of relevant secuities accquired


 Highest price paid (Note 3)


 Lowest price paid (Note 3)




  1,937,315


 83.0300 USD


 79.6350 USD



 



 Total number of relevant secuities disposed


 Highest price paid (Note 3)


 Lowest price paid (Note 3)




  1,920,804


 83.0300 USD


 79.6300 USD



 
 
(b)           Derivatives transactions (other than options transactions)
 



 Product name, e.g. CFD


 Nature of transaction 
                (Note 4)


 Number of relevant securities 
                (Note 5)


 Price per unit




 N/A


 N/A


 N/A


 N/A 



 
 
(c)            Options transactions in respect of existing relevant securities
 
i)           Writing, selling, purchasing or varying
 



 Product name, eg call option


 Writing, selling, purchasing, varying etc


 Number of securities to which the option relates (Note 5)


 Exercise Price


 Type, e.g American, European etc 


 Expiry Date 


 Option money paid/received per unit (Note 3)




 PUT


 PURCHASE


 100


 72.5000


A


 17/04/2020


 0.0400 USD




 PUT


 PURCHASE


 100


 75.0000


A


 17/04/2020


 0.1200 USD




 CALL


 PURCHASE


 100


 83.0000


A


 17/04/2020


 0.3900 USD




 CALL


 PURCHASE


 100


 84.0000


A


 24/04/2020


 0.5300 USD




 CALL


 PURCHASE


 100


 90.0000


A


 15/05/2020


 0.6900 USD




 CALL


 PURCHASE


 100


 90.0000


A


 15/05/2020


 0.6900 USD




 CALL


 PURCHASE


 100


 85.0000


A


 24/04/2020


 0.7200 USD




 PUT


 PURCHASE


 500


 82.0000


A


 17/04/2020


 0.7300 USD




 CALL


 PURCHASE


 100


 90.0000


A


 15/05/2020


 0.8000 USD




 CALL


 PURCHASE


 200


 90.0000


A


 15/05/2020


 1.0100 USD




 CALL


 PURCHASE


 100


 90.0000


A


 15/05/2020


 1.0100 USD




 PUT


 PURCHASE


 100


 70.0000


A


 15/05/2020


 1.0600 USD




 CALL


 PURCHASE


 100


 85.0000


A


 15/05/2020


 1.8800 USD




 PUT


 PURCHASE


 100


 75.0000


A


 19/06/2020


 2.5000 USD




 CALL


 PURCHASE


 100


 90.0000


A


 21/08/2020


 3.2300 USD




 CALL


 SALE


 300


 105.0000


A


 19/06/2020


 0.1300 USD




 CALL


 SALE


 200


 115.0000


A


 21/08/2020


 0.2200 USD




 CALL


 SALE


 300


 81.0000


A


 17/04/2020


 1.0000 USD




 CALL


 SALE


 100


 85.0000


A


 15/05/2020


 1.9700 USD




 CALL


 SALE


 100


 90.0000


A


 19/06/2020


 2.1800 USD




 PUT


 SALE


 100


 60.0000


A


 20/11/2020


 2.4900 USD




 CALL


 SALE


 500


 87.5000


A


 19/06/2020


 2.6000 USD




 CALL


 SALE


 300


 82.5000


A


 15/05/2020


 3.5900 USD




 CALL


 SALE


 400


 82.5000


A


 15/05/2020


 3.6400 USD




 CALL


 SALE


 200


 82.5000


A


 19/06/2020


 4.0700 USD




 CALL


 SALE


 100


 85.0000


A


 19/06/2020


 4.1500 USD




 CALL


 SALE


 200


 85.0000


A


 19/06/2020


 4.1500 USD




 CALL


 SALE


 500


 80.0000


A


 19/06/2020


 5.4200 USD




 CALL


 SALE


 100


 77.5000


A


 15/05/2020


 5.5700 USD




 CALL


 SALE


 100


 80.0000


A


 15/01/2021


 8.6900 USD



 
(ii) Exercising
 



 Product name, eg call option


 Number of securities


 Exercise price per unit (Note 3)




 N/A


 N/A


 N/A  



 
 
3. OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 



Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
 




 
 
 
 
 



 
 



 Date of disclosure


 16 APRIL 2020




 Contact Name


Craig Horsley




 Telephone Number


+44(141) 245 7736 




 Name of offeree/offeror with which connected


ABBVIE INC. 




Nature of connection (Note 6)


Advisory 



 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
ISESFESUMESSEEL